(30 days)
GlideScope® BFlex™ Single-Use Bronchoscopes are intended to work with the video monitor, in conjunction with nonpowered endoscopic accessories and other ancillary equipment for endoscopy within the airways and tracheobronchial tree.
The GlideScope® BFlex™ 3.8 Single-Use Bronchoscope is one component of the GlideScope® BFlex™ Single-Use Bronchoscope System. The system consists of a single-use flexible bronchoscope, a reusable monitor, and a reusable cable. The GlideScope® BFlex™ Single-Use Bronchoscope System is intended to provide real time viewing and recording for a wide range of airway procedures. Similar to the predicate GlideScope® BFlex™ 5.0 and 5.8 Single-Use Bronchoscopes, the GlideScope® BFlex™ 3.8 Single-Use Bronchoscope is distributed sterile and is for single use only. The GlideScope® BFlex™ bronchoscopes operate with a portable reusable GlideScope video monitor (GVM or Core monitor) for purposes of image display.
The provided text is a 510(k) Summary for the GlideScope® BFlex™ 3.8 Single-Use Bronchoscope. This document focuses on demonstrating substantial equivalence to predicate devices and describes the results of performance testing.
Here's an analysis of the requested information based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The text states, "Results: All testing resulted in acceptance criteria passed." However, specific quantitative acceptance criteria or detailed device performance metrics are not explicitly provided in the summary. The "Technological Characteristic" table compares the proposed device to predicates, indicating "Same" or specific values for certain features, but these are characteristics, not performance metrics against acceptance criteria.
| Type of Testing / Characteristic | Acceptance Criteria (Implicit) | Reported Device Performance |
|---|---|---|
| Full System Requirements Testing | Meets established requirements | Passed |
| Electrical Safety (AAMI/ANSI ES60601-1, IEC 60601-2-18) | Complies with standards | Passed |
| Electromagnetic Compatibility (ANSI AAMI IEC 60601-1-2) | Complies with standards | Passed |
| Optical testing (ISO 8600-1, ISO 8600-3, ISO 8600-4) | Complies with standards | Passed |
| Biocompatibility (ANSI AAMI ISO 10993-1) | Complies with standards | Passed |
| Aging Performance Testing | Meets established requirements | Passed |
| Sterile Packaging Integrity Testing | Meets established requirements | Passed |
| Cleaning Testing | Meets established requirements | Passed |
| Design Validation | Meets established requirements | Passed |
2. Sample Size Used for the Test Set and Data Provenance
The document does not specify sample sizes for the performance tests conducted. It details types of tests performed (e.g., electrical safety, optical testing) but not the number of units tested. The data provenance is not explicitly stated as country of origin, retrospective or prospective for these engineering and performance tests, but it is implied to be internal testing by the manufacturer (Verathon Medical (Canada) ULC).
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This information is not provided. The performance testing described appears to be engineering and design verification/validation against established standards and internal specifications, rather than clinical studies requiring expert ground truth for a test set.
4. Adjudication Method for the Test Set
This information is not applicable and hence not provided. The testing described does not involve expert adjudication as it is not a clinical study or a study comparing interpretations.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance
No MRMC comparative effectiveness study was conducted or mentioned in the document. The device is a bronchoscope, not an AI-powered diagnostic tool for interpretation.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
No standalone algorithm performance study was conducted or mentioned. The device is a physical medical instrument (bronchoscope), not an algorithm.
7. The Type of Ground Truth Used
For the engineering and performance testing described, the "ground truth" would be the acceptance criteria defined by the relevant international standards (e.g., ISO, AAMI, IEC) and the manufacturer's own design specifications. It is not expert consensus, pathology, or outcomes data in a clinical sense.
8. The Sample Size for the Training Set
No training set is mentioned or applicable, as this device is a physical bronchoscope, not an AI/machine learning system that requires a training set.
9. How the Ground Truth for the Training Set Was Established
Not applicable, as there is no training set for this device.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, and the word "ADMINISTRATION" in a smaller font size below.
January 16, 2020
Verathon Medical (Canada) ULC Teresa Davidson Director, Regulatory Affairs 2227 Douglas Road Burnaby, BC V3W 1P2 Canada
Re: K193488
Trade/Device Name: GlideScope BFlex 3.8 Single-Use Bronchoscope Regulation Number: 21 CFR 874.4680 Regulation Name: Bronchoscope (Flexible or Rigid) and Accessories Regulatory Class: Class II Product Code: EOQ Dated: December 16, 2019 Received: December 17, 2019
Dear Teresa Davidson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for Michael Ryan Director DHT1C: Division of ENT, Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K193488
Device Name
GlideScope® BFlex™ 3.8 Single-Use Bronchoscope
Indications for Use (Describe)
GlideScope® BFlex™ Single-Use Bronchoscopes are intended to work with the video monitor, in conjunction with nonpowered endoscopic accessories and other ancillary equipment for endoscopy within the airways and tracheobronchial tree.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for Verathon. The logo consists of a stylized "V" shape in teal, with the word "VERATHON" in teal, sans-serif font to the right of the "V". The "V" shape is formed by two curved lines that converge at the bottom, resembling a stylized plant or sprout.
510(K) SUMMARY
This summary of Safety and Effectiveness is provided as part of this Premarket Notification in compliance with 21 CFR 807, Subpart E, section 807.92.
Submitter:
Verathon Medical (Canada) ULC 2227 Douglas Road Burnaby, BC V3W 1P2 Canada
Contact Person:
Teresa Davidson Director, Regulatory Affairs Phone: (425) 629-5516 Email: Teresa.davidson@verathon.com
Date Summary Prepared:
December 16, 2019
Establishment Registration Number:
Verathon Medical (Canada) ULC Registration Number: 9615393 Owner/Operator Number: 9095489
Device Trade or Proprietary Name:
GlideScope® BFlex™ 3.8 Single-Use Bronchoscope
Device Common or Usual Name:
Flexible Bronchoscope
| Device Trade or Proprietary Name | Device Common or Usual Name |
|---|---|
| GlideScope® BFlex™ 3.8 Single-UseBronchoscope | Flexible Bronchoscope |
Device Classification:
| Classification Name | Class | Product Code | Classification Regulation |
|---|---|---|---|
| Bronchoscope (Flexible orRigid) and Accessories | II | EOQ | 21 CFR 874.4680 |
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the Verathon logo. The logo consists of a stylized "V" shape in blue and green, followed by the word "VERATHON" in blue. The "V" shape is formed by two intersecting lines, with the left line in blue and the right line in green. The word "VERATHON" is in a sans-serif font, with a registered trademark symbol after the word.
Review Panel:
Ear. Nose, and Throat
Predicate Device:
The features and functions of the proposed GlideScope® BFlex™ 3.8 Single-Use Bronchoscope is substantially equivalent to the previously cleared GlideScope® BFlex™ 5.0 and 5.8 Single-Use Bronchoscopes. The 510(k) clearance numbers and respective clearance dates for the predicate devices are included in the table below:
| Predicate Device | 510(k) Number | Clearance Date |
|---|---|---|
| GlideScope® BFlex™ 5.0 Single-UseBronchoscope | K183256 | January 04, 2019 |
| GlideScope® BFlex™ 5.8 Single-UseBronchoscope | K191948 | August 21, 2019 |
Device Description:
The GlideScope® BFlex™ 3.8 Single-Use Bronchoscope is one component of the GlideScope® BFlex™ Single-Use Bronchoscope System. The system consists of a single-use flexible bronchoscope, a reusable monitor, and a reusable cable. The GlideScope® BFlex™ Single-Use Bronchoscope System is intended to provide real time viewing and recording for a wide range of airway procedures.
Similar to the predicate GlideScope® BFlex™ 5.0 and 5.8 Single-Use Bronchoscopes, the GlideScope® BFlex™ 3.8 Single-Use Bronchoscope is distributed sterile and is for single use only. The GlideScope® BFlex™ bronchoscopes operate with a portable reusable GlideScope video monitor (GVM or Core monitor) for purposes of image display.
Intended Use:
GlideScope® BFlex™ Single-Use bronchoscopes are intended to work with a video monitor, in conjunction with non-powered endoscopic accessories and other ancillary equipment for endoscopy within the airways and tracheobronchial tree.
Intended Patient Population:
The GlideScope® BFlex™ Single-Use system is for use in a hospital environment. The GlideScope® BFlex™ bronchoscope is a single-use device designed for use in adults. It
has been verified and validated for the following endotracheal tube (ETT) and endoscope accessory (EA) sizes:
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for Verathon. The logo consists of a stylized green checkmark-like symbol on the left, followed by the word "VERATHON" in blue, sans-serif font. A small registration mark is present to the right of the word.
| Model | Minimum ETT Internal Diameter | EA Minimum Working ChannelWidth |
|---|---|---|
| BFlex 3.8 | 5.0 mm | 1.2 mm |
| BFlex 5.0 | 6.0 mm | 2.1 mm |
| BFlex 5.8 | 7.0 mm | 3.0 mm |
Technological Characteristics:
The proposed subject GlideScope® BFlex™ 3.8 Single-Use Bronchoscope when compared to the predicate bronchoscopes has similar technological characteristics. See the comparison table below for similarities and differences between the proposed and predicate devices:
| TechnologicalCharacteristic | PredicateGlideScope®BFlex™ 5.0Single-UseBronchoscope | PredicateGlideScope®BFlex™ 5.8Single-UseBronchoscope | ProposedGlideScope®BFlex™ 3.8Single-UseBronchoscope |
|---|---|---|---|
| Flexible Endoscope | Yes | Yes | Yes |
| Size DistinguishingColor(Non-patientcontacting) | Blue | Yellow | Purple |
| Working ChannelMaterial(Patient contacting) | ThermoplasticPolyurethane(Medical grade) | ThermoplasticPolyurethane(Medical grade) | Fluoropolymer(Medical grade) |
| Tip sheath adhesiveand primer material(Patient contacting) | No | No | Yes |
| Outside Diameter ofFlexible InsertionTube/Shaft andMinimum InternalDiameter ofWorking Channel | 5.0mm2.1mm | 5.8mm3.0mm | 3.8mm1.2mm |
| Suction Button | Yes | Yes | Yes |
| Single UseBronchoscope | Yes | Yes | Yes |
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image shows the Verathon logo. The logo consists of a stylized "V" shape in green and blue, followed by the word "VERATHON" in blue. The "V" shape is formed by two curved lines that meet at a point, with the left side in green and the right side in blue. The word "VERATHON" is in a sans-serif font, with a registered trademark symbol next to the "N".
| TechnologicalCharacteristic | PredicateGlideScope®BFlex™ 5.0Single-UseBronchoscope | PredicateGlideScope®BFlex™ 5.8Single-UseBronchoscope | ProposedGlideScope®BFlex™ 3.8Single-UseBronchoscope |
|---|---|---|---|
| Sterility | Sterile byEthylene Oxide(EO) | Same | Same |
| ControlButton for Tip | Yes | Yes | Yes |
| Power Source | RechargeableLithium-ionBattery | Same | Same |
| Camera | Yes | Yes | Yes |
| Direction of View,Relative to | 0° | Same | Same |
| Field ofview. | 85° | Same | Same |
| Field of View, | 120° | Same | Same |
| Depth of Field | 5-50mm | Same | Same |
| Image Resolution | 640x480 | Same | Same |
| LED Light Source | Yes | Yes | Yes |
| Image Display | Displays imageon a ReusableVideo Monitor | Same | Same |
| Extended Viewing | Yes | Yes | Yes |
Performance Testing:
Performance testing has been completed to demonstrate that the proposed GlideScope® BFlex™ 3.8 Single-Use Bronchoscope meets the safety and performance requirements established in the design specifications. Comprehensive verification and validation testing included the following:
- Full System Requirements Testing ィ
- Electrical Safety according to ィ
- o AAMI / ANSI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and A2:2010/(R)2012 (Consolidated Text) Medical electrical equipment
- Part 1: General requirements for basic safety and essential performance
- o IEC 60601-2-18: Edition 3.0 2009-08
- o AAMI / ANSI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and A2:2010/(R)2012 (Consolidated Text) Medical electrical equipment
{7}------------------------------------------------
Image /page/7/Picture/0 description: The image shows the Verathon logo. The logo consists of a stylized "V" shape in green and blue, followed by the word "VERATHON" in blue, sans-serif font. A small circle is present to the right of the word "VERATHON".
Medical electrical equipment - Part 2-18: Particular requirements for the basic safety and essential performance of endoscopic equipment
- Electromagnetic Compatibility according to
- ANSI AAMI IEC 60601-1-2:2014 Edition 4.0 o Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests (Edition 4)
- Optical testing according to
- ISO 8600-1 Fourth Edition 2015-10-15 Endoscopes - Medical endoscopes and endotherapy devices -- Part 1: General requirements
- o ISO 8600-3 First edition 1997-07-01 (Amendment 1 2003-12-01 Optics and Optical instruments - Medical endoscopes and endoscopic accessories - Part 3: Determination of field of view and direction of view of endoscopes with optics [Including: Amendment 1 (2003)]
- ISO 8600-4 Second Edition 2014-03-15 Endoscopes - Medical endoscopes and certain accessories - Part 4: Determination of maximum width of insertion portion
- Biocompatibility according to
- o ANSI AAMI ISO 10993-1:2009/(R)2013 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
- Aging Performance Testing ﻬ
- Sterile Packaging Integrity Testing r
- Cleaning Testing ﻬ
- Design Validation
Results: All testing resulted in acceptance criteria passed.
Summary of Clinical Tests:
The GlideScope® BFlex™ 3.8 Single-Use Bronchoscope, subject of this submission, did not require clinical studies to support the determination of substantial equivalence.
Conclusion:
The information in this 510(k) Premarket Notification demonstrates that the proposed GlideScope® BFlex™ 3.8 Single-Use Bronchoscope is substantially equivalent to the previously cleared predicate GlideScope® BFlex™ 5.0 and 5.8 Single-Use Bronchoscopes with respect to safety, effectiveness, and performance.
§ 874.4680 Bronchoscope (flexible or rigid) and accessories.
(a)
Identification. A bronchoscope (flexible or rigid) and accessories is a tubular endoscopic device with any of a group of accessory devices which attach to the bronchoscope and is intended to examine or treat the larynx and tracheobronchial tree. It is typically used with a fiberoptic light source and carrier to provide illumination. The device is made of materials such as stainless steel or flexible plastic. This generic type of device includes the rigid ventilating bronchoscope, rigid nonventilating bronchoscope, nonrigid bronchoscope, laryngeal-bronchial telescope, flexible foreign body claw, bronchoscope tubing, flexible biopsy forceps, rigid biopsy curette, flexible biopsy brush, rigid biopsy forceps, flexible biopsy curette, and rigid bronchoscope aspirating tube, but excludes the fiberoptic light source and carrier.(b)
Classification. Class II.